About

About Cytovale Cytovale is a medical diagnostics company focused on providing a more rapid and insightful way to diagnose fast-moving and immune-mediated diseases. Cytovale’s FDA-cleared IntelliSep sepsis test is pioneering a new way of quickly and accurately analyzing white blood cells (WBCs) to stratify a patient’s risk of sepsis from a standard blood draw in ~8 minutes. The IntelliSep test categorizes patients into three bands according to their probability of sepsis. The results may equip providers with a tool to optimize clinical outcomes and empower hospitals to improve resource utilization and achieve operational excellence. For more information, please visit our website: www.cytovale.com